This inventor holds 21 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Biomedical Research. Top assignees: University of California, Cor Therapeutics, Inc., Pfizer Corporation. Active years: 1984-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boston, MA (US) (1984)
- San Francisco, CA (US) (1993 - 2006)
- Tiburon, CA (US) (1998 - 2021)
Company Filing History:
18 out of 16,025 
5 out of 92 
1 out of 4,488 
Years Active: 1984-2021
Areas of Expertise:
Title: Shaun R. Coughlin: Innovator in Coagulation and Chemokine Research
Introduction
Shaun R. Coughlin, based in Tiburon, CA, is a prominent innovator and inventor in the field of biomedical sciences, holding a remarkable 21 patents. His patents primarily focus on advancements in coagulation and chemokine receptor research, demonstrating his influential role in therapeutic development.
Latest Patents
Among his latest innovations, Shaun has worked on several groundbreaking patents. One notable patent is for "Antibodies to coagulation factor XIa and uses thereof." This invention involves antibodies or antigen-binding fragments that specifically target activated Factor XI (FXIa). It also includes methods for obtaining these antibodies, as well as compositions aimed at the therapeutic prevention of thrombotic diseases and disorders. Another significant patent focuses on "Methods of screening for antagonists of mammalian monocyte chemoattractant protein receptors." This work unveils novel human chemokine receptors, MCP-1RA and MCP-1RB, which can be utilized in assays to identify MCP-1 antagonists useful for treating atherosclerosis and similar diseases characterized by monocytic infiltrates.
Career Highlights
Shaun has had a distinguished career, contributing to notable research institutions such as the University of California and Cor Therapeutics, Inc. His work has emphasized the intersection of innovative research and practical therapeutic applications, significantly advancing our understanding of coagulation and inflammatory mechanisms.
Collaborations
Throughout his career, Shaun has collaborated with esteemed professionals, including Robert M. Scarborough and Israel F. Charo. These collaborations have fostered a rich environment for exchanging ideas and facilitating the development of transformative therapies in the biomedical field.
Conclusion
Shaun R. Coughlin’s extensive contributions to science through his patents and collaboration with significant institutions and colleagues highlight his role as a leading figure in biomedical innovation. His work continues to pave the way for new therapeutic approaches, underscoring the vital link between invention and healthcare advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile